Hongbo Zhang - UTU Research Portal

Hongbo Zhang

Turku Bioscience Centre (Independent units)

hongbo.zhang@utu.fi

Publications

7 of 17

A molecularly imprinted antibiotic receptor on magnetic nanotubes for the detection and removal of environmental oxytetracyclineBionic Microbubble Neutrophil Composite for Inflammation- Responsive Atherosclerotic Vulnerable Plaque Pluripotent Intervention (2022)
- Journal of Materials Chemistry. B
Wang Jixiang, Li Xiaolei, Zhang Rong, Fu Bingjie, Chen Mingcan, Ye Mengxue, Liu Wanyu, Xu Jingjing, Pan Guoqing, Zhang Hongbo
(A1 Refereed original research article in a scientific journal)
A pH-Responsive Cluster Metal-Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect (2022)
- Advanced MaterialsResearch
Cheng Ruoyu, Jiang Lingxi, Gao Han, Liu Zehua, Mäkilä Ermei, Wang Shiqi, Saiding Qimanguli, Xiang Lei, Tang Xiaomei, Shi Minmin, Liu Jia, Pang Libin, Salonen Jarno, Hirvonen Jouni, Zhang Hongbo, Cui Wenguo, Shen Baiyong, Santos Hélder A.
(A1 Refereed original research article in a scientific journal)
2022
Liu Fangfang, Mao Yang, Yan Jiaqi, Sun Yu, Xie Zhihua, Li Fei, Yan Fei, Zhang Hongbo, Zhang Pengfei
(A1 Refereed original research article in a scientific journal)
Breaking the Iron Homeostasis: A ?Trojan Horse? Self-Assembled Nanodrug Sensitizes Homologous Recombination Proficient Ovarian Cancer Cells to PARP Inhibition br (2022)
- ACS Nano
Li Yangyang, Cen Yixuan, Fang Yifeng, Tang Sangsang, Li Sen, Ren Yan, Zhang Hongbo, Lu Weiguo, Xu Junfen
(A1 Refereed original research article in a scientific journal)
Co-Delivery of Paclitaxel Prodrug, Gemcitabine and Porphine by Micelles for Pancreatic Cancer Treatment via Chemo-Photodynamic Combination TherapyDelivery of therapeutic oligonucleotides in nanoscale (2022)
- PharmaceuticsBioactive Materials
Wu Qiwei, Ma Xiaodong, Zhou Wenhui, Yu Rong, Rosenholm Jessica M, Tian Weizhong, Zhang Lirong, Wang Dongqing, Zhang HongboA1 Refereed original research article in a scientific journal
Combination of photothermal, prodrug and tumor cell camouflage technologies for triple-negative breast cancer treatment (2022)
- MATERIALS TODAY ADVANCES
Zhang Lirong, Ma Xiaodong, Zhou Wenhui, Wu Qiwei, Yan Jiaqi, Xu Xiaoyu, Ghimire Bhawana, Rosenholm Jessica M, Feng Jing, Wang Dongqing, Zhang Hongbo
(A1 Refereed original research article in a scientific journal)
(2022)
Wu Lei, Zhou Wenhui, Lin Lihua, Chen Anhong, Feng Jing, Qu Xiangmeng, Zhang Hongbo, Yue Jun
(A2 Refereed review article in a scientific journal )
Editorial: Functional and Smart Biomaterials: Development and Application in Regenerative Medicine (2022)
- Frontiers in Bioengineering and Biotechnology
Li Guicai, Zhang Hongbo
(B1 Non-refereed article in a scientific journal)
Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy (2022)
- Science Advances
Zhang Jiahui, Ji Cheng, Zhang Hongbo, Shi Hui, Mao Fei, Qian Hui, Xu Wenrong, Wang Dongqing, Pan Jianming, Fang Xinjian, Santos Helder A., Zhang Xu
(A1 Refereed original research article in a scientific journal)
Helper T Cell (CD4(+)) Targeted Tacrolimus Delivery Mediates Precise Suppression of Allogeneic Humoral Immunity (2022)
- Research
Shen Jia, Liu Chang, Yan Pengpeng, Wang Meifang, Guo Luying, Liu Shuaihui, Chen Jianghua, Rosenholm Jessica M, Huang Hongfeng, Wang Rending, Zhang Hongbo
(A1 Refereed original research article in a scientific journal)